GB2160861B - Prazosin hydrochloride - Google Patents

Prazosin hydrochloride

Info

Publication number
GB2160861B
GB2160861B GB08424999A GB8424999A GB2160861B GB 2160861 B GB2160861 B GB 2160861B GB 08424999 A GB08424999 A GB 08424999A GB 8424999 A GB8424999 A GB 8424999A GB 2160861 B GB2160861 B GB 2160861B
Authority
GB
United Kingdom
Prior art keywords
prazosin hydrochloride
prazosin
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08424999A
Other languages
English (en)
Other versions
GB8424999D0 (en
GB2160861A (en
Inventor
Stig Olof Engelbert Lindholm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Fermion Oy
Original Assignee
Orion Yhtyma Fermion Oy
Orion Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtyma Fermion Oy, Orion Yhtyma Oy filed Critical Orion Yhtyma Fermion Oy
Publication of GB8424999D0 publication Critical patent/GB8424999D0/en
Publication of GB2160861A publication Critical patent/GB2160861A/en
Application granted granted Critical
Publication of GB2160861B publication Critical patent/GB2160861B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
GB08424999A 1984-06-25 1984-10-03 Prazosin hydrochloride Expired GB2160861B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI842544A FI79107C (fi) 1984-06-25 1984-06-25 Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.

Publications (3)

Publication Number Publication Date
GB8424999D0 GB8424999D0 (en) 1984-11-07
GB2160861A GB2160861A (en) 1986-01-02
GB2160861B true GB2160861B (en) 1987-11-18

Family

ID=8519293

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08424999A Expired GB2160861B (en) 1984-06-25 1984-10-03 Prazosin hydrochloride

Country Status (17)

Country Link
US (2) US4739055A (https=)
JP (1) JPS6115881A (https=)
AT (1) AT389117B (https=)
AU (1) AU566814B2 (https=)
BE (1) BE900925A (https=)
CH (1) CH661045A5 (https=)
DE (1) DE3429415A1 (https=)
FI (1) FI79107C (https=)
FR (1) FR2567124B1 (https=)
GB (1) GB2160861B (https=)
IL (1) IL73267A (https=)
IT (1) IT1224142B (https=)
LU (1) LU85616A1 (https=)
NL (1) NL8403250A (https=)
NZ (1) NZ209962A (https=)
PT (1) PT79411B (https=)
ZA (1) ZA85910B (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3683760D1 (de) * 1986-03-21 1992-03-12 Heumann Pharma Gmbh & Co Kristalline, wasserfreie sigma -form von 2-(4-(2-furoyl-(2-piperazin)-1-yl)-4-amino-6,7-dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung.
JP2756846B2 (ja) * 1989-12-28 1998-05-25 住化ファインケム株式会社 無水のε型結晶体２―〔４―（２―フロイル）ピペラジン―１―イル〕―４―アミノ―６，７―ジメトキシキナゾリン塩酸塩及びその製造方法
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
KR100926247B1 (ko) * 2001-02-24 2009-11-12 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 크산틴 유도체를 포함하는 약제학적 조성물 및 이의제조방법
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
KR101452915B1 (ko) * 2006-05-04 2014-10-21 베링거 인겔하임 인터내셔날 게엠베하 다형태
BRPI0815405A2 (pt) * 2007-08-17 2015-02-03 Boehringer Ingelheim Int Compostos derivados de purina, processo para a preparação de uma composição farmacêutica e uso dos mesmos
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
KR20190016601A (ko) 2008-08-06 2019-02-18 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UA119131C2 (uk) * 2008-08-15 2019-05-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх Похідні пурину для застосування при лікуванні пов'язаних із fab захворювань
CA2736421A1 (en) 2008-09-10 2010-03-18 Boehringer Ingelheim International Gmbh Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
JP2012512848A (ja) 2008-12-23 2012-06-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 有機化合物の塩の形態
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
KR20240090632A (ko) 2009-11-27 2024-06-21 베링거 인겔하임 인터내셔날 게엠베하 리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
CA3070513C (en) 2010-05-05 2023-01-03 Boehringer Ingelheim International Gmbh A dpp-4 inhibitor for use in treatment of skin-alterations or necrosis
KR20130093012A (ko) 2010-06-24 2013-08-21 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 요법
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
DK2731947T3 (en) 2011-07-15 2019-04-23 Boehringer Ingelheim Int SUBSTITUTED DIMERIC QUINAZOLINE DERIVATIVE, PREPARATION AND USE thereof IN PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF TYPE I AND TYPE II DIABETES
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
WO2013171166A1 (en) 2012-05-14 2013-11-21 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp-4 inhibitor for use in the treatment of sirs and/or sepsis
WO2013171167A1 (en) 2012-05-14 2013-11-21 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
EP3110449B1 (en) 2014-02-28 2023-06-28 Boehringer Ingelheim International GmbH Medical use of a dpp-4 inhibitor
EP4233840A3 (en) 2016-06-10 2023-10-18 Boehringer Ingelheim International GmbH Combinations of linagliptin and metformin

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2969375A (en) * 1961-01-24 Certification of correction
DE156532C (https=) *
NL54420C (https=) * 1937-05-25
GB1156973A (en) * 1965-07-06 1969-07-02 Quinazoline Derivatives
US3433788A (en) * 1966-04-27 1969-03-18 Union Carbide Corp Process for recovery of amines from aqueous solutions by solvent treatment and distillation
US3421983A (en) * 1967-03-07 1969-01-14 Lummus Co Azeotropic distillation of aqueous toluene diamine
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3743672A (en) * 1970-05-27 1973-07-03 Halcon International Inc Separation of water in alkylene glycol mono and diester purification by azeotropic distillation
GB1308718A (en) * 1970-07-01 1973-03-07 Sir Soc Italiana Resine Spa Method of separating vinyl acetate from liquid mixtures
IT956765B (it) * 1972-06-22 1973-10-10 Montedison Spa Procedimento per la purificazione di 1 3 diossolano
US3935213A (en) * 1973-12-05 1976-01-27 Pfizer Inc. Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4001237A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company Oxazole, isoxazole, thiazole and isothiazole amides
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
FI64367C (fi) * 1980-02-26 1986-08-05 Orion Yhtymae Oy Foerfarande foer framstaellning av alfa-form av prazosinhydroklorid

Also Published As

Publication number Publication date
FI842544L (fi) 1985-12-26
NZ209962A (en) 1987-06-30
BE900925A (fr) 1985-02-15
US4739055A (en) 1988-04-19
IT1224142B (it) 1990-09-26
US4873330A (en) 1989-10-10
IL73267A (en) 1988-06-30
IL73267A0 (en) 1985-01-31
GB8424999D0 (en) 1984-11-07
IT8423292A0 (it) 1984-10-24
AU3451084A (en) 1986-01-02
NL8403250A (nl) 1986-01-16
ATA344184A (de) 1989-03-15
FR2567124B1 (fr) 1990-09-21
FI79107C (fi) 1989-11-10
FR2567124A1 (fr) 1986-01-10
LU85616A1 (fr) 1985-06-04
PT79411B (en) 1986-09-15
AU566814B2 (en) 1987-10-29
ZA85910B (en) 1985-09-25
JPS6115881A (ja) 1986-01-23
GB2160861A (en) 1986-01-02
DE3429415C2 (https=) 1990-05-03
FI842544A0 (fi) 1984-06-25
AT389117B (de) 1989-10-25
JPH0481993B2 (https=) 1992-12-25
PT79411A (en) 1984-11-01
CH661045A5 (de) 1987-06-30
FI79107B (fi) 1989-07-31
DE3429415A1 (de) 1986-01-02

Similar Documents

Publication Publication Date Title
GB2160861B (en) Prazosin hydrochloride
GB8506474D0 (en) Producing diphenylamines
AU95743S (en) Telelphone set
EP0183535A3 (en) Self-correcting printer-verifier
GB8530186D0 (en) Supports
PH21512A (en) N-(naphthyl-alkyl)-hydroxy-amines
GB8415254D0 (en) Amine derivatives
ZA85116B (en) 3-alkoxy-2-(n-pyrrolidino)-n-pyrimidinyl-or-n-pyrazinylpropylamines
GB8407957D0 (en) Golf
GB2166657B (en) Golf aid
GB8514417D0 (en) Preparing aminobenzylamine
ZA85274B (en) N-(naphthyl-alkyl)-hydroxylamines
GB8422037D0 (en) Putting aid
YU40084A (en) Hidraulic soft constant cateter
GB8530759D0 (en) 2-nitro-4-amino anilines
CS867284A1 (en) Sposob stanovenia obsahu n nitrozodimetylaminu
NZ227556A (en) 1-alkoxy-1-methylethoxy amines
GB8416158D0 (en) Amines
KR860000566Y1 (en) Golf-club
GB8423937D0 (en) Aminoalkanols
GB8410346D0 (en) Putting aid
GB8425472D0 (en) Golfers aid
CS595084A1 (en) Sposob chromatografickej izolacie alditolov z ich zmesi
GB8401272D0 (en) Polyamines
BG38181A1 (en) Antimycotic means

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20021003